Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings

BACKGROUND: Despite concerns about affordability and sustainability, many models of the lifetime costs of antiretroviral therapy (ART) used in resource limited settings are based on data from small research cohorts, together with pragmatic assumptions about life-expectancy. This paper revisits these...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Leisegang, Rory, Maartens, Gary, Hislop, Michael, Regensberg, Leon, Cleary, Susan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2010
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895747/
https://ncbi.nlm.nih.gov/pubmed/20594369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-10-S1-S3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares